Shearman & Sterling advised Albemarle Corporation on its $1.3 billion registered public offering of its common stock.

Albemarle intends to use the net proceeds of this offering primarily to fund growth capital expenditures, such as the construction and expansion of lithium operations in Australia, Chile and Silver Peak, Nevada, and opportunities in China.

Albemarle Corporation is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts.

The Team